Ampersand Capital Partners portfolio company Avista Pharma Solutions (APS) has acquired Solid Form Solutions Limited (SFS).

The target company will operate from Edinburgh, Scotland, following the acquisition.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The acquisition will strengthen APS’s solid phase chemistry services.

Based in the UK, APS is a contract development and manufacturing organisation, while SFS is also based in the UK and involved in providing solid-state chemistry and crystallisation development services.

“The acquisition will help Venn Life Sciences Holdings to reinforce its data management and clinical capabilities.”

Venn Life Sciences Holdings Plc has increased its stake in Venn Life Sciences (France) SAS (VLSF) to 100% by acquiring the remaining 11.03% stake in the target company from Christian Le Bras (CLB).

CLB will continue to operate as head of interactive response technology in VLS, following the acquisition.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The acquisition will help Venn Life Sciences Holdings to reinforce its data management and clinical capabilities.

Both companies are clinical research organisations based in France.

Clinical Trials Arena Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Clinical Trials Arena Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving clinical trials industry advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now